CUMBERLAND PHARMACEUTICALS INC (ticker: CPIX) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of CPIX's SEC filings surfaces 2 active risk signals, including 2 auditor-change signals. CPIX reported $9.13M in revenue and -$3.29M for the period ending 2026-03-31, with operating cash flow of $387K. Cash and equivalents stood at $11.01M (down 27.1% year-over-year). Total assets of $71.00M exceed total liabilities of $49.69M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
CPIX Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for CUMBERLAND PHARMACEUTICALS INC (CPIX) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.